Eurofins Scientific updated its 2026 guidance after weaker than usual market conditions and cancelled clinical programmes, indicating organic growth is now expected to sit below its earlier mid single ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-10-29 05:01:00









